Hamps Bio shares made a strong stock market debut with a premium of 90 percent over the issue price on the BSE SME platform on December 20, following a premium of 1,003.3 times to its Rs 6.22 crore ...

Hamps Bio shares were listed - at a 90% premium over the IPO price - on BSE SME platform today. The IPO which closed on ...

The pharma company, which received bids worth ₹6,242.5 crore for its ₹6.22 crore issue, is the third most subscribed SME IPO of the year.

The pharma company, which received bids worth ₹6,242.5 crore for its ₹6.22 crore issue, is the third most subscribed SME IPO ...

Hamps Bio shares debuted on BSE SME at ₹96.90, 90% above the issue price of ₹51, and were locked in a 5% upper circuit. The ...

Hamps Bio’s shares soar with a 90% premium debut on BSE SME; IPO oversubscribed 1000 times, showcasing robust investor ...

Hamps Bio IPO sees a 1,057 times subscription on the final day of bidding. Discover more about this strong market debut!

After listing, the Hamps Bio shares gained an additional 5 per cent, surging 99.49 per cent from the issue price to reach the ...

Check Hamps Bio IPO allotment status today online via BSE or Bigshare Services and explore the grey market premium.

The unlisted shares of Hamps Bio were trading at Rs 106, reflecting a grey market premium (GMP) of Rs 55, or 107.84 per cent ...

The initial share sale of Hamps Bio Ltd. saw a massive demand from investors during the three-day subscription period.

Investors subscribed for 122.4 crore equity shares in three days compared to the offer size of 12.2 lakh shares, through 4.23 ...